Disease | N. SNPs d | DSI v | DPI v | Chr | Position | Consequence | Alleles | Class | AFEXOME | AFGENOME | Score vda | EI vda | N. PMIDs | First Ref. | Last Ref. | ||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Colon Carcinoma
|
275 | 0.554 | 0.680 | 10 | 112998590 | intron variant | C/G;T | snv | 0.020 | 1.000 | 2 | 2008 | 2008 | ||||||
Coronary Arteriosclerosis
|
440 | 0.554 | 0.680 | 10 | 112998590 | intron variant | C/G;T | snv | 0.020 | 1.000 | 2 | 2008 | 2009 | ||||||
Diabetic Retinopathy
|
213 | 0.554 | 0.680 | 10 | 112998590 | intron variant | C/G;T | snv | 0.020 | 1.000 | 2 | 2014 | 2015 | ||||||
Fasting blood sugar result
|
113 | 0.554 | 0.680 | 10 | 112998590 | intron variant | C/G;T | snv | 0.700 | 1.000 | 2 | 2012 | 2012 | ||||||
Hypertriglyceridemia
|
169 | 0.554 | 0.680 | 10 | 112998590 | intron variant | C/G;T | snv | 0.020 | 1.000 | 2 | 2010 | 2015 | ||||||
Impaired insulin secretion
|
14 | 0.554 | 0.680 | 10 | 112998590 | intron variant | C/G;T | snv | 0.020 | 1.000 | 2 | 2009 | 2010 | ||||||
Kidney Diseases
|
140 | 0.554 | 0.680 | 10 | 112998590 | intron variant | C/G;T | snv | 0.020 | 1.000 | 2 | 2011 | 2014 | ||||||
Latent Autoimmune Diabetes in Adults
|
12 | 0.554 | 0.680 | 10 | 112998590 | intron variant | C/G;T | snv | 0.020 | 1.000 | 2 | 2019 | 2019 | ||||||
Malignant neoplasm of colon and/or rectum
|
502 | 0.554 | 0.680 | 10 | 112998590 | intron variant | C/G;T | snv | 0.020 | 1.000 | 2 | 2008 | 2018 | ||||||
Malignant neoplasm of prostate
|
1082 | 0.554 | 0.680 | 10 | 112998590 | intron variant | C/G;T | snv | 0.020 | 1.000 | 2 | 2010 | 2014 | ||||||
Malignant Neoplasms
|
1641 | 0.554 | 0.680 | 10 | 112998590 | intron variant | C/G;T | snv | 0.020 | 1.000 | 2 | 2012 | 2016 | ||||||
Peripheral Arterial Diseases
|
128 | 0.554 | 0.680 | 10 | 112998590 | intron variant | C/G;T | snv | 0.710 | 1.000 | 2 | 2019 | 2020 | ||||||
Prediabetes syndrome
|
16 | 0.554 | 0.680 | 10 | 112998590 | intron variant | C/G;T | snv | 0.020 | 1.000 | 2 | 2015 | 2017 | ||||||
Primary malignant neoplasm
|
1374 | 0.554 | 0.680 | 10 | 112998590 | intron variant | C/G;T | snv | 0.020 | 1.000 | 2 | 2012 | 2016 | ||||||
Prostate carcinoma
|
1168 | 0.554 | 0.680 | 10 | 112998590 | intron variant | C/G;T | snv | 0.020 | 1.000 | 2 | 2010 | 2014 | ||||||
Schizophrenia
|
2897 | 0.554 | 0.680 | 10 | 112998590 | intron variant | C/G;T | snv | 0.710 | 1.000 | 2 | 2011 | 2018 | ||||||
Adenocarcinoma of the gastroesophageal junction
|
6 | 0.554 | 0.680 | 10 | 112998590 | intron variant | C/G;T | snv | 0.010 | 1.000 | 1 | 2019 | 2019 | ||||||
Atherogenic dyslipidaemia
|
9 | 0.554 | 0.680 | 10 | 112998590 | intron variant | C/G;T | snv | 0.010 | 1.000 | 1 | 2009 | 2009 | ||||||
Autoantibody measurement
|
52 | 0.554 | 0.680 | 10 | 112998590 | intron variant | C/G;T | snv | 0.700 | 1.000 | 1 | 2009 | 2009 | ||||||
Autonomic neuropathy
|
7 | 0.554 | 0.680 | 10 | 112998590 | intron variant | C/G;T | snv | 0.010 | 1.000 | 1 | 2013 | 2013 | ||||||
Birth Weight
|
369 | 0.554 | 0.680 | 10 | 112998590 | intron variant | C/G;T | snv | 0.700 | 1.000 | 1 | 2019 | 2019 | ||||||
Carcinoma of lung
|
1204 | 0.554 | 0.680 | 10 | 112998590 | intron variant | C/G;T | snv | 0.010 | 1.000 | 1 | 2018 | 2018 | ||||||
Cholangiocarcinoma
|
43 | 0.554 | 0.680 | 10 | 112998590 | intron variant | C/G;T | snv | 0.010 | 1.000 | 1 | 2017 | 2017 | ||||||
Chronic kidney disease stage 5
|
194 | 0.554 | 0.680 | 10 | 112998590 | intron variant | C/G;T | snv | 0.010 | 1.000 | 1 | 2014 | 2014 | ||||||
Constitutional obesity
|
3 | 0.554 | 0.680 | 10 | 112998590 | intron variant | C/G;T | snv | 0.010 | 1.000 | 1 | 2008 | 2008 |